126 related articles for article (PubMed ID: 35076745)
1. Therapeutic strategies, oncologic and swallowing outcomes and their predictive factors in patients with locally advanced hypopharyngeal cancer.
Mattei P; Thamphya B; Chamorey E; Scheller B; Château Y; Dassonville O; Poissonnet G; Culié D; Koulmann PH; Hechema R; Sudaka A; Saada E; Benezery K; Demard F; Elaldi R; Bozec A
Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3629-3637. PubMed ID: 35076745
[TBL] [Abstract][Full Text] [Related]
2. Induction chemotherapy-based larynx preservation program for locally advanced hypopharyngeal cancer: oncologic and functional outcomes and prognostic factors.
Bozec A; Benezery K; Ettaiche M; Chamorey E; Vandersteen C; Dassonville O; Poissonnet G; Riss JC; Hannoun-Lévi JM; Chand ME; Leysalle A; Saada E; Guigay J; Sudaka A; Demard F; Santini J; Peyrade F
Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3299-306. PubMed ID: 26858198
[TBL] [Abstract][Full Text] [Related]
3. Docetaxel-Cisplatin-Fluorouracil Induction Chemotherapy for Larynx Preservation in Patients with Locally Advanced Hypopharyngeal Cancer: Predictive Factors of Oncologic and Functional Outcomes.
Mattei P; Gal J; Chamorey E; Dassonville O; Poissonnet G; Aloi D; Barret M; Safta I; Saada E; Sudaka A; Culié D; Bozec A
J Clin Med; 2023 Feb; 12(3):. PubMed ID: 36769779
[TBL] [Abstract][Full Text] [Related]
4. Nutritional status and feeding-tube placement in patients with locally advanced hypopharyngeal cancer included in an induction chemotherapy-based larynx preservation program.
Bozec A; Benezery K; Chamorey E; Ettaiche M; Vandersteen C; Dassonville O; Poissonnet G; Riss JC; Hannoun-Lévi JM; Chand ME; Leysalle A; Saada E; Sudaka A; Haudebourg J; Hebert C; Falewee MN; Demard F; Santini J; Peyrade F
Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2681-7. PubMed ID: 26395117
[TBL] [Abstract][Full Text] [Related]
5. Contemporary therapeutic management of locally advanced hypopharyngeal cancer: oncologic and functional outcomes - a report on 100 cases.
Vandersteen C; Benezery K; Chamorey E; Ettaiche M; Dassonville O; Poissonnet G; Riss JC; Pierre CS; Hannoun-Lévi JM; Chand ME; Leyssale A; Peyrade F; Sudaka A; Haudebourg J; Demard F; Santini J; Bozec A
Acta Otolaryngol; 2015 Feb; 135(2):193-200. PubMed ID: 25578129
[TBL] [Abstract][Full Text] [Related]
6. Long-term oncological and functional outcomes of induction chemotherapy followed by (chemo)radiotherapy vs definitive chemoradiotherapy vs surgery-based therapy in locally advanced stage III/IV hypopharyngeal cancer: Multicenter review of 266 cases.
Chung EJ; Jeong WJ; Jung YH; Kwon SK; Kwon TK; Ahn SH; Sung MW; Keam B; Heo DS; Kim JH; Wu HG; Lee KW; Eom KY; Rho YS
Oral Oncol; 2019 Feb; 89():84-94. PubMed ID: 30732965
[TBL] [Abstract][Full Text] [Related]
7. Patients with locally advanced hypopharyngeal carcinoma. Results over a 30-year period.
León X; López M; García J; Rovira C; Casasayas M; Quer M
Acta Otorrinolaringol Esp (Engl Ed); 2019; 70(6):315-326. PubMed ID: 30527320
[TBL] [Abstract][Full Text] [Related]
8. Salvage vs. Primary Total Laryngectomy in Patients with Locally Advanced Laryngeal or Hypopharyngeal Carcinoma: Oncologic Outcomes and Their Predictive Factors.
Shoushtari ST; Gal J; Chamorey E; Schiappa R; Dassonville O; Poissonnet G; Aloi D; Barret M; Safta I; Saada E; Sudaka A; Culié D; Bozec A
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835841
[TBL] [Abstract][Full Text] [Related]
9. [Comparative analysis of clinical efficacies between induction chemotherapy and surgery combined with radiotherapy or concurrent chemoradiotherapy in advanced hypopharyngeal carcinoma].
Li ZD; Lu T
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Dec; 53(12):918-924. PubMed ID: 30585004
[No Abstract] [Full Text] [Related]
10. Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer.
Zelefsky MJ; Kraus DH; Pfister DG; Raben A; Shah JP; Strong EW; Spiro RH; Bosl GJ; Harrison LB
Head Neck; 1996; 18(5):405-11. PubMed ID: 8864731
[TBL] [Abstract][Full Text] [Related]
11. Predicting Factors for Oncological and Functional Outcome in Hypopharyngeal Cancer.
Visini M; Giger R; Shelan M; Elicin O; Anschuetz L
Laryngoscope; 2021 May; 131(5):E1543-E1549. PubMed ID: 33098325
[TBL] [Abstract][Full Text] [Related]
12. [A retrospective study on combined modality therapy with or without surgery for advanced hypopharyngeal squamous cell carcinoma: an analysis of 119 cases].
Zhang YX; Peng HH; Zhang XX; Zhao JD; Wu WM; Wang JL; Huang DL; Zong L; Chen LW; Liu CQ; Liu MB
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):352-358. PubMed ID: 29764016
[No Abstract] [Full Text] [Related]
13. Definitive Chemoradiation in Locally Advanced Squamous Cell Carcinoma of the Hypopharynx: Long-term Outcomes and Toxicity.
Juloori A; Koyfman SA; Geiger JL; Joshi NP; Woody NM; Burkey BB; Scharpf J; Lamarre EL; Prendes B; Adelstein DJ; Greskovich JF; Keller L
Anticancer Res; 2018 Jun; 38(6):3543-3549. PubMed ID: 29848708
[TBL] [Abstract][Full Text] [Related]
14. Oncologic outcomes following robot-assisted radical cystectomy with minimum 5-year follow-up: the Roswell Park cancer institute experience.
Raza SJ; Al-Daghmin A; Zhuo S; Mehboob Z; Wang K; Wilding G; Kauffman E; Guru KA
Eur Urol; 2014 Nov; 66(5):920-8. PubMed ID: 24768522
[TBL] [Abstract][Full Text] [Related]
15. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
16. Predisposing factors for larynx preservation strategies with non-surgical multimodality treatment for locally advanced (T3-4) larynx, hypopharynx and cervical esophageal disease.
Suzuki G; Yamazaki H; Ogo E; Abe T; Eto H; Muraki K; Hattori C; Umeno H; Tanaka N; Tanaka T; Nakamura S; Yoshida K
Anticancer Res; 2014 Sep; 34(9):5205-10. PubMed ID: 25202116
[TBL] [Abstract][Full Text] [Related]
17. Subjective voice quality, communicative ability and swallowing after definitive radio(chemo)therapy, laryngectomy plus radio(chemo)therapy, or organ conservation surgery plus radio(chemo)therapy for laryngeal and hypopharyngeal cancer.
Szuecs M; Kuhnt T; Punke C; Witt G; Klautke G; Kramp B; Hildebrandt G
J Radiat Res; 2015 Jan; 56(1):159-68. PubMed ID: 25348250
[TBL] [Abstract][Full Text] [Related]
18. Larynx preservation using induction chemotherapy plus radiation therapy as an alternative to laryngectomy in advanced head and neck cancer. A long-term follow-up report.
Karp DD; Vaughan CW; Carter R; Willett B; Heeren T; Calarese P; Zeitels S; Strong MS; Hong WK
Am J Clin Oncol; 1991 Aug; 14(4):273-9. PubMed ID: 1713738
[TBL] [Abstract][Full Text] [Related]
19. Definitive Chemoradiotherapy Versus Surgery Followed by Adjuvant Radiotherapy in Resectable Stage III/IV Hypopharyngeal Cancer.
Kim JW; Kim MS; Kim SH; Kim JH; Lee CG; Kim GE; Keum KC
Cancer Res Treat; 2016 Jan; 48(1):45-53. PubMed ID: 25779363
[TBL] [Abstract][Full Text] [Related]
20. Pyriform sinus squamous cell carcinoma: oncological outcomes in good responders of induction chemotherapy-based larynx preservation protocols.
Vourexakis Z; Le Ridant AM; Dulguerov P; Janot F
Eur Arch Otorhinolaryngol; 2015 Jul; 272(7):1725-31. PubMed ID: 24854231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
